Cibus Global and NEU Seed to Develop Potato Crop Protection and Performance Enhancement Traits for North America.
Potato bruising costs the U.S. potato industry nearly $300 million a year* and NEU Seed estimates that 60 percent of this is attributable to blackspot bruise. In addition to yielding significant economic advantages for farmers and consumers through reduced waste, NEU Seed and Cibus have focused on newly developed traits that are expected to reduce usage of pesticides and improve the sustainability of potato production. Eventually the partners intend to collaborate on the development of other important traits to create healthier potato plants with improved quality attributes that will benefit the consumer and potato industry.
RTDS is an environmentally safe, trait development procedure that will use the potato's natural process of gene repair to effect a precise change in the genetic sequence. By mimicking natural methods in a highly targeted way, RTDS technology avoids the introduction of foreign genetic material into plants. RTDS has been recognized by the USDA as a mutagenesis technique, and is therefore not subject to the regulations applied to transgenic (or GM) crops. Mutagenesis-derived crops and traits are produced around the globe in a number of food categories, including grains (rice, oats, durum wheat), vegetable oil crops (sunflower, canola, flax), beer ingredients (barley, hops, yeast) and seedless fruits (grapes, citrus fruits).
Cibus President Dr. Keith Walker said, "RTDS technology is revolutionary in that it enables the development in plants of valuable traits that enhance overall efficiency and product quality through a natural process. Globally, potato is a very important food crop, and Cibus is proud to work with NEU Seed and the potato industry to enhance production and quality for the benefit of farmers, processers and consumers."
"Cibus offers the potato industry a naturally accelerated breeding process that will lead to new and innovative technology solutions for the farmer," said Dirk Parkinson, potato grower and President of NEU Seed, from Saint Anthony, Idaho. "The RTDS technology offers North American farmers the ability to develop valuable traits through a carefully targeted process that mimics what occurs in nature. This directed and efficient approach allows for lower production costs and significantly enhances the overall quality of our product for our customers."
* "Preventing Potato Bruise Damage," edited by Michael Thornton and William Bohl. College of Agriculture, University of Idaho. 1998. http://info.ag.uidaho.edu/resources/PDFs/BUL0725.pdf
About Cibus Global
Cibus Global (www.cibus.com) develops advantageous crop traits with far-reaching implications in agriculture, alternative energy and product development. Through its proprietary Rapid Trait Development System (RTDS(TM)), Cibus creates traits in a directed way with more precision than traditional breeding techniques and without the introduction of foreign genetic material. RTDS has proven itself in the laboratory with several different applications, as well as in initial field trials of Cibus' first commercial crop, canola. Cibus' products will be brought to market through a number of strategic partnerships; in September 2009, Cibus announced an alliance with Israeli-based Makhteshim-Agan to develop five crops with a European focus.
About NEU Seed
Naturally Enhanced United Seed (NEU Seed) was formed in November 2008 to develop and market potato cultivars with new innovative traits for growers, processors and consumers. NEU Seed is a cooperative of seed potato growers, based in Rexburg, Idaho, with a membership of growers from both Idaho and Montana. NEU Seed has entered into partnering agreements with Cibus Global and is seeking seed potato grower members from other seed producing areas of North America to join with NEU Seed to bring value added potato traits to market.
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 2, 2009|
|Previous Article:||ECM Provider KnowledgeTree[R] Releases Version 3.7 of Its Document Management Software.|
|Next Article:||First Subject Dosed in Phase 1B Clinical Trial of Phosphagenics' Patented Oxycodone Patch.|